ZUMA-19 gets FDA approval after phase 2 no other drugs on the market for this indication. Data point read outs are off the charts so far and is safe.
Sonic Boom short squeeze from the stock gods is coming.
HGEN has all the boxes checked. Adding a 43% shares short of the float can bring in a whole new pool of investors. A billion dollar drug weeks away for CV-19 from EUA. They have countries in Asia and Europe ready to go. $100.00 price target is in the cards. With a billion in potential revenue coming down the pipe. Looking for new all time highs in the near future. I love that 55% of the shares are being held by insiders and institutions float is very small.
Market Data 
Markets 
AI
